Skip to main content
Erschienen in: European Journal of Trauma and Emergency Surgery 2/2021

14.10.2019 | Original Article

Fractures in Parkinson’s Disease: injury patterns, hospitalization, and therapeutic aspects

verfasst von: Nils Mühlenfeld, Nicolas Söhling, Ingo Marzi, Martin Pieper, Esther Paule, Philipp S. Reif, Adam Strzelczyk, René D. Verboket, Laurent M. Willems

Erschienen in: European Journal of Trauma and Emergency Surgery | Ausgabe 2/2021

Einloggen, um Zugang zu erhalten

Abstract

Aim

The primary aim of this study was to analyze the frequency and characteristic patterns of fall-related fractures as well as consecutive hospitalization and management relating to such fractures. In addition, important pathognomonic and therapeutic aspects are discussed.

Methods

This retrospective mono-center study was conducted at the University Hospital Frankfurt am Main, Germany. Between 2007 and 2017, a total of 145 PD patients with fall-related fractures were identified via a retrospective systematic query in the hospital information system using the ICD-10 German modification codes G20.0–G20.9. Patients with unclear or falsely coded PD were strictly excluded.

Results

The mean age of the cohort was 77.7 years (± 7.5, median 77.) and 57.9% of the cohort were females (n = 84). A total number of 151 fractures were reported, with 140 patients (96.6%) suffering from one, four patients from two (2.8%), and one patient from three fractures (0.6%) at a time. For 43.9% (n = 65) of the cohort, fractures concerned lower extremities (LE) followed by trunk (38.1%, n = 58) and upper extremities (UE, 17.9%, n = 27). Most common fracture types in LE were femoral neck fractures (52.3%, n = 34). Mean length of hospital stay (LOS) was 13.6 days (95% CI 12.4–14.7). In 43.4% (n = 63) of cases, an interim admission to an intensive-care unit (ICU) was necessary. Mean ICU LOS was 2.3 days (95% CI 1.5–3.0), and mean LOS for normal care unit was 10.5 days (95% CI 10.3–12.4). Surgical treatment was necessary in 75.9% of the cases (n = 110). Patients undergoing surgical treatment showed significantly longer LOS compared to conservatively treated patients (p < 0.001). Moreover, fractures of the LE (p = 0.018) and UE (p = 0.010) were associated with a significant longer LOS.

Conclusion

Fall-related fractures are a common and relevant complication in PD patients leading to increased immobility, frequent hospitalization, and immediate surgical care. Fractures of the lower extremities and trunk were the most common in the cohort for this study. A PD patient presenting to the emergency room or at the general practitioner with a fracture should always be checked for osteoporosis and a fall-related injury should be seen as a red flag for reviewing a patient’s individual therapeutic regime.
Literatur
1.
Zurück zum Zitat de Lau LML, Breteler MMB. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5:525–35.CrossRefPubMed de Lau LML, Breteler MMB. Epidemiology of Parkinson's disease. Lancet Neurol. 2006;5:525–35.CrossRefPubMed
2.
Zurück zum Zitat Gaba A. Recent studies on nutrition and Parkinson's disease prevention: a systematic review. Open J Prev Med. 2015;5(5):197–205.CrossRef Gaba A. Recent studies on nutrition and Parkinson's disease prevention: a systematic review. Open J Prev Med. 2015;5(5):197–205.CrossRef
3.
Zurück zum Zitat Martinez-Martin P, Macaulay D, Jalundhwala YJ, Mu F, Ohashi E, Marshall T, et al. The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United States. Mov Disord. 2018;22:146. Martinez-Martin P, Macaulay D, Jalundhwala YJ, Mu F, Ohashi E, Marshall T, et al. The long-term direct and indirect economic burden among Parkinson's disease caregivers in the United States. Mov Disord. 2018;22:146.
4.
Zurück zum Zitat Rogers G, Davies D, Pink J, Cooper P. Parkinson's disease: summary of updated NICE guidance. BMJ. 2017;358:j1951.PubMedCrossRef Rogers G, Davies D, Pink J, Cooper P. Parkinson's disease: summary of updated NICE guidance. BMJ. 2017;358:j1951.PubMedCrossRef
5.
Zurück zum Zitat Abou-Raya S, Helmii M, Abou-Raya A. Bone and mineral metabolism in older adults with Parkinson's disease. Age Ageing. 2009;38:675–80.PubMedCrossRef Abou-Raya S, Helmii M, Abou-Raya A. Bone and mineral metabolism in older adults with Parkinson's disease. Age Ageing. 2009;38:675–80.PubMedCrossRef
6.
Zurück zum Zitat Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N. Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors. J Neurol. 2005;252:1310–5.PubMedCrossRef Balash Y, Peretz C, Leibovich G, Herman T, Hausdorff JM, Giladi N. Falls in outpatients with Parkinson's disease: frequency, impact and identifying factors. J Neurol. 2005;252:1310–5.PubMedCrossRef
7.
Zurück zum Zitat Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson's disease. J Neurol. 2001;248:950–8.PubMedCrossRef Bloem BR, Grimbergen YA, Cramer M, Willemsen M, Zwinderman AH. Prospective assessment of falls in Parkinson's disease. J Neurol. 2001;248:950–8.PubMedCrossRef
8.
Zurück zum Zitat Matinolli M, Korpelainen JT, Sotaniemi KA, Myllylä VV, Korpelainen R. Recurrent falls and mortality in Parkinson's disease: a prospective two-year follow-up study. Acta Neurol Scand. 2011;123:193–200.PubMedCrossRef Matinolli M, Korpelainen JT, Sotaniemi KA, Myllylä VV, Korpelainen R. Recurrent falls and mortality in Parkinson's disease: a prospective two-year follow-up study. Acta Neurol Scand. 2011;123:193–200.PubMedCrossRef
9.
Zurück zum Zitat Pickering RM, Grimbergen YAM, Rigney U, Ashburn A, Mazibrada G, Wood B, et al. A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord. 2007;22:1892–900.PubMedCrossRef Pickering RM, Grimbergen YAM, Rigney U, Ashburn A, Mazibrada G, Wood B, et al. A meta-analysis of six prospective studies of falling in Parkinson's disease. Mov Disord. 2007;22:1892–900.PubMedCrossRef
10.
Zurück zum Zitat Wielinski CL, Erickson-Davis C, Wichmann R, Walde-Douglas M, Parashos SA. Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromes. Mov Disord. 2005;20:410–5.PubMedCrossRef Wielinski CL, Erickson-Davis C, Wichmann R, Walde-Douglas M, Parashos SA. Falls and injuries resulting from falls among patients with Parkinson's disease and other parkinsonian syndromes. Mov Disord. 2005;20:410–5.PubMedCrossRef
11.
Zurück zum Zitat Tan AH, Hew YC, Lim S-Y, Ramli NM, Kamaruzzaman SB, Tan MP, et al. Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease. Parkinsonism Relat Disord. 2018;56:58–64.PubMedCrossRef Tan AH, Hew YC, Lim S-Y, Ramli NM, Kamaruzzaman SB, Tan MP, et al. Altered body composition, sarcopenia, frailty, and their clinico-biological correlates, in Parkinson's disease. Parkinsonism Relat Disord. 2018;56:58–64.PubMedCrossRef
12.
Zurück zum Zitat Paul SS, Harvey L, Canning CG, Boufous S, Lord SR, Close JCT, et al. Fall-related hospitalization in people with Parkinson's disease. Eur J Neurol. 2017;24:523–9.PubMedCrossRef Paul SS, Harvey L, Canning CG, Boufous S, Lord SR, Close JCT, et al. Fall-related hospitalization in people with Parkinson's disease. Eur J Neurol. 2017;24:523–9.PubMedCrossRef
13.
Zurück zum Zitat Braga M, Pederzoli M, Antonini A, Beretta F, Crespi V. Reasons for hospitalization in Parkinson's disease: a case-control study. Parkinsonism Relat Disord. 2014;20:488–92 (discussion 488).PubMedCrossRef Braga M, Pederzoli M, Antonini A, Beretta F, Crespi V. Reasons for hospitalization in Parkinson's disease: a case-control study. Parkinsonism Relat Disord. 2014;20:488–92 (discussion 488).PubMedCrossRef
14.
Zurück zum Zitat Temlett JA, Thompson PD. Reasons for admission to hospital for Parkinson's disease. Intern Med J. 2006;36(8):524–6.PubMedCrossRef Temlett JA, Thompson PD. Reasons for admission to hospital for Parkinson's disease. Intern Med J. 2006;36(8):524–6.PubMedCrossRef
15.
16.
Zurück zum Zitat Arbouw MEL, Movig KLL, van Staa TP, Egberts ACG, Souverein PC, de Vries F. Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. Osteoporos Int. 2011;22:2197–204.PubMedCrossRef Arbouw MEL, Movig KLL, van Staa TP, Egberts ACG, Souverein PC, de Vries F. Dopaminergic drugs and the risk of hip or femur fracture: a population-based case-control study. Osteoporos Int. 2011;22:2197–204.PubMedCrossRef
17.
Zurück zum Zitat Cevallos M, Egger M. STROBE (STrengthening the Reporting of Observational studies in Epidemiology). Guidelines for Reporting Health Research: a user's manual. Oxford: Wiley; 2014. p. 169–179. Cevallos M, Egger M. STROBE (STrengthening the Reporting of Observational studies in Epidemiology). Guidelines for Reporting Health Research: a user's manual. Oxford: Wiley; 2014. p. 169–179.
18.
Zurück zum Zitat Harron K, Benchimol E, Langan S. Using the RECORD guidelines to improve transparent reporting of studies based on routinely collected data. Int J Popul Data Sci. 2018;3:2.PubMed Harron K, Benchimol E, Langan S. Using the RECORD guidelines to improve transparent reporting of studies based on routinely collected data. Int J Popul Data Sci. 2018;3:2.PubMed
19.
Zurück zum Zitat Taylor S, Curri T, Lawless M, Sen S, Greenhalgh DG, Palmieri TL. Predicting resource utilization in burn treatment. J Burn Care Res. 2014;35(Suppl 2):S235–S246246.PubMedCrossRef Taylor S, Curri T, Lawless M, Sen S, Greenhalgh DG, Palmieri TL. Predicting resource utilization in burn treatment. J Burn Care Res. 2014;35(Suppl 2):S235–S246246.PubMedCrossRef
21.
Zurück zum Zitat Del Din S, Galna B, Godfrey A, et al. Analysis of free-living gait in older adults with and without Parkinson's disease and with and without a history of falls: identifying generic and disease-specific characteristics. J Gerontol A Biol Sci Med Sci. 2019;74(4):500–6.PubMedCrossRef Del Din S, Galna B, Godfrey A, et al. Analysis of free-living gait in older adults with and without Parkinson's disease and with and without a history of falls: identifying generic and disease-specific characteristics. J Gerontol A Biol Sci Med Sci. 2019;74(4):500–6.PubMedCrossRef
22.
Zurück zum Zitat Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ. Bone health in Parkinson's disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2014;85:1159–66.PubMedCrossRef Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ. Bone health in Parkinson's disease: a systematic review and meta-analysis. J Neurol Neurosurg Psychiatry. 2014;85:1159–66.PubMedCrossRef
23.
Zurück zum Zitat Aminoff MJ, Christine CW, Friedman JH, Chou KL, Lyons KE, Pahwa R, et al. Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism Relat Disord. 2011;17:139–45.PubMedCrossRef Aminoff MJ, Christine CW, Friedman JH, Chou KL, Lyons KE, Pahwa R, et al. Management of the hospitalized patient with Parkinson's disease: current state of the field and need for guidelines. Parkinsonism Relat Disord. 2011;17:139–45.PubMedCrossRef
24.
Zurück zum Zitat Benzinger P, Rapp K, Maetzler W, König H-H, Jaensch A, Klenk J, et al. Risk for femoral fractures in Parkinson's disease patients with and without severe functional impairment. Toft M, editor. PLoS ONE. 2014;9:e97073.PubMedPubMedCentralCrossRef Benzinger P, Rapp K, Maetzler W, König H-H, Jaensch A, Klenk J, et al. Risk for femoral fractures in Parkinson's disease patients with and without severe functional impairment. Toft M, editor. PLoS ONE. 2014;9:e97073.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Melton LJ, Leibson CL, Achenbach SJ, Bower JH, Maraganore DM, Oberg AL, et al. Fracture risk after the diagnosis of Parkinson's disease: influence of concomitant dementia. Mov Disord. 2006;21:1361–7.PubMedCrossRef Melton LJ, Leibson CL, Achenbach SJ, Bower JH, Maraganore DM, Oberg AL, et al. Fracture risk after the diagnosis of Parkinson's disease: influence of concomitant dementia. Mov Disord. 2006;21:1361–7.PubMedCrossRef
26.
Zurück zum Zitat Yiannopoulou KG, Papageorgiou SG, Anastasiou IP, Ganetsos TK, Karydakis KD. Prevalence of Parkinsonism in older patients with hip fracture. Hip Int. 2011;21:351–5.PubMedCrossRef Yiannopoulou KG, Papageorgiou SG, Anastasiou IP, Ganetsos TK, Karydakis KD. Prevalence of Parkinsonism in older patients with hip fracture. Hip Int. 2011;21:351–5.PubMedCrossRef
27.
Zurück zum Zitat Creaby MW, Cole MH. Gait characteristics and falls in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2018;57:1–8.PubMedCrossRef Creaby MW, Cole MH. Gait characteristics and falls in Parkinson's disease: a systematic review and meta-analysis. Parkinsonism Relat Disord. 2018;57:1–8.PubMedCrossRef
28.
Zurück zum Zitat Tomic S, Pekic V, Popijac Z, Pucic T, Vinkovic MP, Kuric TG, et al. Hyperhomocysteinemia influenced malnutrition in Parkinson's disease patients. Neurol Sci. 2018;39:1691–5.PubMedCrossRef Tomic S, Pekic V, Popijac Z, Pucic T, Vinkovic MP, Kuric TG, et al. Hyperhomocysteinemia influenced malnutrition in Parkinson's disease patients. Neurol Sci. 2018;39:1691–5.PubMedCrossRef
29.
Zurück zum Zitat Lee JY, Lim NG, Chung CK, Lee J-Y, Kim HJ, Park SB. Parkinson's disease as risk factor in osteoporosis and osteoporotic vertebral fracture prevalence study using national inpatient sample database in Korea. J Korean Neurosurg Soc. 2019;62:71–82.PubMedCrossRef Lee JY, Lim NG, Chung CK, Lee J-Y, Kim HJ, Park SB. Parkinson's disease as risk factor in osteoporosis and osteoporotic vertebral fracture prevalence study using national inpatient sample database in Korea. J Korean Neurosurg Soc. 2019;62:71–82.PubMedCrossRef
30.
Zurück zum Zitat Rimmelzwaan LM, van Schoor NM, Lips P, Berendse HW, Eekhoff EMW. Systematic review of the relationship between vitamin D and Parkinson's disease. J Parkinsons Dis. 2016;6:29–37.PubMedPubMedCentralCrossRef Rimmelzwaan LM, van Schoor NM, Lips P, Berendse HW, Eekhoff EMW. Systematic review of the relationship between vitamin D and Parkinson's disease. J Parkinsons Dis. 2016;6:29–37.PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Tassorelli C, Berlangieri M, Buscone S, Bolla M, De Icco R, Baricich A, et al. Falls, fractures and bone density in Parkinson's disease—a cross-sectional study. Int J Neurosci. 2017;127:299–304.PubMedCrossRef Tassorelli C, Berlangieri M, Buscone S, Bolla M, De Icco R, Baricich A, et al. Falls, fractures and bone density in Parkinson's disease—a cross-sectional study. Int J Neurosci. 2017;127:299–304.PubMedCrossRef
32.
Zurück zum Zitat Verboket RD, Söhling N, Marzi I, Paule E, Knake S, Rosenow F, et al. Prevalence, risk factors and therapeutic aspects of injuries and accidents in women with epilepsy. Eur J Trauma Emerg Surg. 2018;55:475–7. Verboket RD, Söhling N, Marzi I, Paule E, Knake S, Rosenow F, et al. Prevalence, risk factors and therapeutic aspects of injuries and accidents in women with epilepsy. Eur J Trauma Emerg Surg. 2018;55:475–7.
33.
Zurück zum Zitat Bisson EJ, Ekuma O, Marrie RA, Leslie WD, Finlayson ML. Factors associated with receiving bone mineral density screening among people with multiple sclerosis. Mult Scler Relat Disord. 2019;28:305–8.PubMedCrossRef Bisson EJ, Ekuma O, Marrie RA, Leslie WD, Finlayson ML. Factors associated with receiving bone mineral density screening among people with multiple sclerosis. Mult Scler Relat Disord. 2019;28:305–8.PubMedCrossRef
34.
Zurück zum Zitat Strzelczyk A, Griebel C, Lux W, Rosenow F, Reese J-P. The burden of severely drug-refractory epilepsy: a comparative longitudinal evaluation of mortality, morbidity, resource use, and cost using german health insurance data. Front Neurol Front. 2017;8:54. Strzelczyk A, Griebel C, Lux W, Rosenow F, Reese J-P. The burden of severely drug-refractory epilepsy: a comparative longitudinal evaluation of mortality, morbidity, resource use, and cost using german health insurance data. Front Neurol Front. 2017;8:54.
35.
Zurück zum Zitat Seebach C, Verboket R. Consequences and treatment aspects of trauma in female patients. Eur J Trauma Emerg Surg. 2019;45:373–4.PubMedCrossRef Seebach C, Verboket R. Consequences and treatment aspects of trauma in female patients. Eur J Trauma Emerg Surg. 2019;45:373–4.PubMedCrossRef
36.
Zurück zum Zitat Willems LM, Watermann N, Richter S, et al. Incidence, risk factors and consequences of epilepsy-related injuries and accidents: A retrospective, single center study. Front Neurol. 2018;9:414.PubMedPubMedCentralCrossRef Willems LM, Watermann N, Richter S, et al. Incidence, risk factors and consequences of epilepsy-related injuries and accidents: A retrospective, single center study. Front Neurol. 2018;9:414.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Malochet-Guinamand S, Durif F, Thomas T. Parkinson's disease: A risk factor for osteoporosis. Jt Bone Spine. 2015;82:406–10.CrossRef Malochet-Guinamand S, Durif F, Thomas T. Parkinson's disease: A risk factor for osteoporosis. Jt Bone Spine. 2015;82:406–10.CrossRef
38.
Zurück zum Zitat Herrmann M, Widmann T, Colaianni G, Colucci S, Zallone A, Herrmann W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem Clin Chem. 2005;51:2348–53.PubMedCrossRef Herrmann M, Widmann T, Colaianni G, Colucci S, Zallone A, Herrmann W. Increased osteoclast activity in the presence of increased homocysteine concentrations. Clin Chem Clin Chem. 2005;51:2348–53.PubMedCrossRef
39.
Zurück zum Zitat Koh J-M, Lee Y-S, Kim YS, Kim DJ, Kim H-H, Park J-Y, et al. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res. 2006;21:1003–111.PubMedCrossRef Koh J-M, Lee Y-S, Kim YS, Kim DJ, Kim H-H, Park J-Y, et al. Homocysteine enhances bone resorption by stimulation of osteoclast formation and activity through increased intracellular ROS generation. J Bone Miner Res. 2006;21:1003–111.PubMedCrossRef
40.
Zurück zum Zitat El Maghraoui A, Ghozlani I, Mounach A, Rezqi A, Oumghar K, Achemlal L, et al. Homocysteine, folate, and vitamin B12 levels and vertebral fracture risk in postmenopausal women. J Clin Densitom. 2012;15:328–33.PubMedCrossRef El Maghraoui A, Ghozlani I, Mounach A, Rezqi A, Oumghar K, Achemlal L, et al. Homocysteine, folate, and vitamin B12 levels and vertebral fracture risk in postmenopausal women. J Clin Densitom. 2012;15:328–33.PubMedCrossRef
41.
Zurück zum Zitat Ikram MA, Brusselle GGO, Murad SD, van Duijn CM, Franco OH, Goedegebure A, et al. The Rotterdam Study: 2018 update on objectives, design and main results. Eur J Epidemiol. 2017;32:807–50.PubMedPubMedCentralCrossRef Ikram MA, Brusselle GGO, Murad SD, van Duijn CM, Franco OH, Goedegebure A, et al. The Rotterdam Study: 2018 update on objectives, design and main results. Eur J Epidemiol. 2017;32:807–50.PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Neue Osteoporose-Leitlinie und Patienteninformation. J Miner Stoffwechs. Muskuloskelet. Erkrank. Springer Vienna. 2018;25:75–6. Neue Osteoporose-Leitlinie und Patienteninformation. J Miner Stoffwechs. Muskuloskelet. Erkrank. Springer Vienna. 2018;25:75–6.
43.
Zurück zum Zitat Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Noya M, Takahashi D, et al. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr. 2013;97:1004–133.PubMedCrossRef Suzuki M, Yoshioka M, Hashimoto M, Murakami M, Noya M, Takahashi D, et al. Randomized, double-blind, placebo-controlled trial of vitamin D supplementation in Parkinson disease. Am J Clin Nutr. 2013;97:1004–133.PubMedCrossRef
44.
Zurück zum Zitat Barradas AMC, Fernandes HAM, Groen N, Chai YC, Schrooten J, van de Peppel J, et al. A calcium-induced signaling cascade leading to osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells. Biomaterials. 2012;33:3205–15.PubMedCrossRef Barradas AMC, Fernandes HAM, Groen N, Chai YC, Schrooten J, van de Peppel J, et al. A calcium-induced signaling cascade leading to osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells. Biomaterials. 2012;33:3205–15.PubMedCrossRef
45.
Zurück zum Zitat Dean ED, Mexas LM, Cápiro NL, McKeon JE, DeLong MR, Pennell KD, et al. 25-Hydroxyvitamin D depletion does not exacerbate MPTP-induced dopamine neuron damage in mice. Block ML, editor. PLoS ONE. 2012;7:e39227.PubMedPubMedCentralCrossRef Dean ED, Mexas LM, Cápiro NL, McKeon JE, DeLong MR, Pennell KD, et al. 25-Hydroxyvitamin D depletion does not exacerbate MPTP-induced dopamine neuron damage in mice. Block ML, editor. PLoS ONE. 2012;7:e39227.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, et al. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res. 2001;904:67–75.PubMedCrossRef Wang JY, Wu JN, Cherng TL, Hoffer BJ, Chen HH, Borlongan CV, et al. Vitamin D(3) attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res. 2001;904:67–75.PubMedCrossRef
47.
Zurück zum Zitat Zoccolella S, Lamberti P, Armenise E, de Mari M, Lamberti SV, Mastronardi R, et al. Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications. Parkinsonism Relat Disord. 2005;11:131–3.PubMedCrossRef Zoccolella S, Lamberti P, Armenise E, de Mari M, Lamberti SV, Mastronardi R, et al. Plasma homocysteine levels in Parkinson's disease: role of antiparkinsonian medications. Parkinsonism Relat Disord. 2005;11:131–3.PubMedCrossRef
48.
Zurück zum Zitat Moore O, Peretz C, Giladi N. Freezing of gait affects quality of life of peoples with Parkinson's disease beyond its relationships with mobility and gait. Mov Disord. 2007;22:2192–5.PubMedCrossRef Moore O, Peretz C, Giladi N. Freezing of gait affects quality of life of peoples with Parkinson's disease beyond its relationships with mobility and gait. Mov Disord. 2007;22:2192–5.PubMedCrossRef
49.
Zurück zum Zitat Ld D. Idiopathisches Parkinson-Syndrom, Entwicklungsstufe: S3, Stand: 1. Januar 2016, Gültig bis: 31. Dezember 2020, AWMF-Registernummer: 030/010. 2016. Ld D. Idiopathisches Parkinson-Syndrom, Entwicklungsstufe: S3, Stand: 1. Januar 2016, Gültig bis: 31. Dezember 2020, AWMF-Registernummer: 030/010. 2016.
50.
Zurück zum Zitat Brandmeir NJ, Brandmeir CL, Carr D, Kuzma K, McInerney J. Deep brain stimulation for Parkinson disease does not worsen or improve postural instability: a prospective cohort trial. Neurosurgery. 2018;83:1173–82.PubMedCrossRef Brandmeir NJ, Brandmeir CL, Carr D, Kuzma K, McInerney J. Deep brain stimulation for Parkinson disease does not worsen or improve postural instability: a prospective cohort trial. Neurosurgery. 2018;83:1173–82.PubMedCrossRef
51.
Zurück zum Zitat Protas EJ, Mitchell K, Williams A, Qureshy H, Caroline K, Lai EC. Gait and step training to reduce falls in Parkinson's disease. NeuroRehabilitation. 2005;20:183–90.PubMedCrossRef Protas EJ, Mitchell K, Williams A, Qureshy H, Caroline K, Lai EC. Gait and step training to reduce falls in Parkinson's disease. NeuroRehabilitation. 2005;20:183–90.PubMedCrossRef
52.
Zurück zum Zitat Abbruzzese G, Pelosin E. Rehabilitation of Parkinson’s disease advanced technologies for the rehabilitation of gait and balance disorders. Cham: Springer International Publishing; 2018. p. 161–170.CrossRef Abbruzzese G, Pelosin E. Rehabilitation of Parkinson’s disease advanced technologies for the rehabilitation of gait and balance disorders. Cham: Springer International Publishing; 2018. p. 161–170.CrossRef
53.
Zurück zum Zitat Thaut MH, Rice RR, Braun Janzen T, Hurt-Thaut CP, McIntosh GC. Rhythmic auditory stimulation for reduction of falls in Parkinson's disease: a randomized controlled study. Clin Rehabil. 2018;33:269215518788615–43. Thaut MH, Rice RR, Braun Janzen T, Hurt-Thaut CP, McIntosh GC. Rhythmic auditory stimulation for reduction of falls in Parkinson's disease: a randomized controlled study. Clin Rehabil. 2018;33:269215518788615–43.
54.
Zurück zum Zitat Kang M-G, Yun SJ, Shin HI, Kim E, Lee HH, Oh B-M, et al. Effects of robot-assisted gait training in patients with Parkinson's disease: study protocol for a randomized controlled trial. Trials. 2019;20:15.PubMedPubMedCentralCrossRef Kang M-G, Yun SJ, Shin HI, Kim E, Lee HH, Oh B-M, et al. Effects of robot-assisted gait training in patients with Parkinson's disease: study protocol for a randomized controlled trial. Trials. 2019;20:15.PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Zhang M, Artan NS, Gu H, Dong Z, Burina Ganatra L, Shermon S, et al. Gait Study of Parkinson's disease subjects using haptic cues with a motorized walker. Sensors (Basel). 2018;18:3549.CrossRef Zhang M, Artan NS, Gu H, Dong Z, Burina Ganatra L, Shermon S, et al. Gait Study of Parkinson's disease subjects using haptic cues with a motorized walker. Sensors (Basel). 2018;18:3549.CrossRef
56.
Zurück zum Zitat Santesso N, Carrasco-Labra A, Brignardello-Petersen R. Hip protectors for preventing hip fractures in older people. Cochrane Bone, Joint and Muscle Trauma Group, editor. Cochrane Database Syst Rev. 2014;32:CD001255. Santesso N, Carrasco-Labra A, Brignardello-Petersen R. Hip protectors for preventing hip fractures in older people. Cochrane Bone, Joint and Muscle Trauma Group, editor. Cochrane Database Syst Rev. 2014;32:CD001255.
Metadaten
Titel
Fractures in Parkinson’s Disease: injury patterns, hospitalization, and therapeutic aspects
verfasst von
Nils Mühlenfeld
Nicolas Söhling
Ingo Marzi
Martin Pieper
Esther Paule
Philipp S. Reif
Adam Strzelczyk
René D. Verboket
Laurent M. Willems
Publikationsdatum
14.10.2019
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Trauma and Emergency Surgery / Ausgabe 2/2021
Print ISSN: 1863-9933
Elektronische ISSN: 1863-9941
DOI
https://doi.org/10.1007/s00068-019-01240-z

Weitere Artikel der Ausgabe 2/2021

European Journal of Trauma and Emergency Surgery 2/2021 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

TEP mit Roboterhilfe führt nicht zu größerer Zufriedenheit

15.05.2024 Knie-TEP Nachrichten

Der Einsatz von Operationsrobotern für den Einbau von Totalendoprothesen des Kniegelenks hat die Präzision der Eingriffe erhöht. Für die postoperative Zufriedenheit der Patienten scheint das aber unerheblich zu sein, wie eine Studie zeigt.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.